CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-15 | Paul Robert Chief Medical Officer | Sale | −3,909 | $29.90 | $117K | 223,719 |
| 2020-06-03 | Yu Calvin Vice President, Finance | Sale | −1,043 | $31.04 | $32K | 110,986 |
| 2020-06-03 | Yu Calvin Vice President, Finance | Sale | −300 | $32.02 | $10K | 110,686 |
| 2020-05-15 | Paul Robert Chief Medical Officer | Sale | −1,900 | $26.15 | $50K | 241,819 |
| 2020-05-15 | Paul Robert Chief Medical Officer | Sale | −5,996 | $27.00 | $162K | 235,823 |
| 2020-05-15 | Paul Robert Chief Medical Officer | Sale | −2,104 | $27.78 | $58K | 233,719 |
| 2020-05-15 | King Robert Chief Development Officer | Sale | −3,365 | $26.24 | $88K | 488,952 |
| 2020-05-15 | King Robert Chief Development Officer | Sale | −8,632 | $27.02 | $233K | 480,320 |
| 2020-05-15 | King Robert Chief Development Officer | Sale | −3,003 | $27.78 | $83K | 477,317 |
| 2020-05-11 | Yaffe Kristine Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-05-11 | Wehner David M. Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-05-11 | SCHELLER RICHARD H Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-05-11 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-05-11 | LAVIGNE LOUIS J JR Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-05-11 | Gerngross Tillman U. Director | Grant or award · Stock Option (right to buy) | +19,274 | 19,274 | ||
| 2020-04-16 | ORBIMED ADVISORS LLC 10% owner | Sale | −47,097 | $23.53 | $1.1M | 5,955,674 |
| 2020-04-16 | ORBIMED ADVISORS LLC 10% owner | Sale | −15,086 | $23.53 | $355K | 1,906,718 |
| 2020-04-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $22.27 | $223K | 243,719 |
| 2020-04-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −17,595 | $23.52 | $414K | 6,002,771 |
| 2020-04-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −5,636 | $23.52 | $133K | 1,921,804 |
Page 24 of 36 · 702 trades